RXM 4768
Alternative Names: 3BP-4768; RXM-4768Latest Information Update: 20 Oct 2023
At a glance
- Originator 3B Pharmaceuticals
- Developer 3B Pharmaceuticals; RefleXion
- Class Antineoplastics; Imaging agents; Radiopharmaceuticals
- Mechanism of Action Ionising radiation emitters; Radionuclide imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Solid tumours